Clinical Trials Directory

Trials / Completed

CompletedNCT01936051

Modeling Between Plasma Concentration and Serotonin Transporter Occupancy Induced by Escitalopram in Obsessive-compulsive Disorder(OCD) Patients

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
Male
Age
20 Years – 35 Years
Healthy volunteers
Not accepted

Summary

To modeling the pharmacokinetic-pharmacodynamic(PK-PD) simulation with the plasma concentration and the transporter occupancy from OCD patients treated with escitalopram. To examine the effect of G2677T/A single nucleotide polymorphism(SNP) of ABCB1 gene to the PK-PD modeling in OCD patients treated with escitalopram.

Detailed description

To measure plasma concentration of escitalopram in OCD patients treated with escitalopram. To measure serotonin transporter occupancy by escitalopram in OCD patients treated with escitalopram. To genotype G2677T/A SNP of ABCB1 gene in OCD patients treated with escitalopram.

Conditions

Timeline

Start date
2012-02-01
Primary completion
2013-10-01
Completion
2013-12-01
First posted
2013-09-05
Last updated
2019-04-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01936051. Inclusion in this directory is not an endorsement.